中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Metabolic Diseases
Viral Diseases
Cancer
Exploratory Indications
Products&Pipeline
Pipeline
Products
Clinical Trials
Partnership
Investors
Financials & Filing
News
Careers
Investors
Financials & Filing
2025
2024
2023
2022
2021
2020
2019
2018
2025
2024
2023
2022
2021
2020
2019
2018
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021
2021-12-03
Announcement - Inside Information - Inclusion in New Catalogue of China National Reimbursement Drug List (NRDL) of ASCLEVIR®/GANOVO® Regimen, an All-Oral Direct Anti-HCV Therapy and Resumption of Trading
2021-12-03
Trading Halt
2021-12-03
Next Day Disclosure Returns - Share Buyback
2021-12-02
Next Day Disclosure Returns - Share Buyback
2021-12-01
Next Day Disclosure Returns - Share Buyback
2021-11-30
Next Day Disclosure Returns - Share Buyback
2021-11-29
Next Day Disclosure Returns - Share Buyback
2021-11-26
Next Day Disclosure Returns - Share Buyback
2021-11-25
Next Day Disclosure Returns - Share Buyback
2021-11-24
«
2
3
4
5
»
浙公网安备 33010802003344号
浙ICP备11050387号-1
